Hubert Schrezenmeier

16PUBLICATIONS
97CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematologyRespiratory diseasesFoetal development and medicineRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 18, 2026
Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.

|Jun 11, 2026
In vivo evidence of effective complement modulation by TriFu in comparison to C5 inhibition and complement depletion.

|Apr 01, 2026
American Society of Hematology 2026 guidelines for the diagnosis and management of severe and very severe acquired aplastic anemia.

Phillip Scheinberg, Debra A O'Neal, Ana Lisa Basquiera

|Jan 29, 2026
Ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria during pregnancy.

Britta Höchsmann, Gloria F Gerber, Wilhelm Leopold

|Jun 14, 2025
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies.

Jens Panse, Bing Han, Jaroslav Cermak

|Dec 19, 2024
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.

Austin Kulasekararaj, Morag Griffin, Caroline Piatek

Pageof 3

Frequent Collaborators

3 joint publications

Austin Kulasekararaj

3 joint publications

Jens Panse

2 joint publications

Britta Höchsmann

2 joint publications

Antonio Risitano